Toll Free: 1-888-928-9744
Published: Oct, 2014 | Pages:
30 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Indian Immunologicals Limited - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Indian Immunologicals Limited - Product Pipeline Review - 2014', provides an overview of the Indian Immunologicals Limited's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Indian Immunologicals Limited's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Indian Immunologicals Limited including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Indian Immunologicals Limited's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Indian Immunologicals Limited's pipeline products Reasons to buy - Evaluate Indian Immunologicals Limited's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Indian Immunologicals Limited in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Indian Immunologicals Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Indian Immunologicals Limited and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Indian Immunologicals Limited - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Indian Immunologicals Limited and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Indian Immunologicals Limited Snapshot 5 Indian Immunologicals Limited Overview 5 Key Information 5 Key Facts 5 Indian Immunologicals Limited - Research and Development Overview 6 Key Therapeutic Areas 6 Indian Immunologicals Limited - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Indian Immunologicals Limited - Pipeline Products Glance 11 Indian Immunologicals Limited - Clinical Stage Pipeline Products 11 Phase I Products/Combination Treatment Modalities 11 Indian Immunologicals Limited - Early Stage Pipeline Products 12 Preclinical Products/Combination Treatment Modalities 12 Indian Immunologicals Limited - Unknown Stage Pipeline Products 13 Unknown Products/Combination Treatment Modalities 13 Indian Immunologicals Limited - Drug Profiles 14 chikungunya vaccine 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 DPT-H-HiB Vaccine 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 haemophilus influenzae vaccine [type B] 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 human papilloma virus vaccine [types 16 and 18] 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 alphavirus vaccine 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 flavivirus vaccine 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Japanese encephalitis vaccine 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 picornavirus vaccine 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 vaccine for cervical cancer 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Vaccine for Undisclosed Indication 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 Indian Immunologicals Limited - Pipeline Analysis 24 Indian Immunologicals Limited - Pipeline Products by Route of Administration 24 Indian Immunologicals Limited - Pipeline Products by Molecule Type 25 Indian Immunologicals Limited - Dormant Projects 26 Indian Immunologicals Limited - Locations And Subsidiaries 27 Head Office 27 Other Locations & Subsidiaries 27 Appendix 29 Methodology 29 Coverage 29 Secondary Research 29 Primary Research 29 Expert Panel Validation 29 Contact Us 30 Disclaimer 30
List of Tables Indian Immunologicals Limited, Key Information 5 Indian Immunologicals Limited, Key Facts 5 Indian Immunologicals Limited - Pipeline by Indication, 2014 8 Indian Immunologicals Limited - Pipeline by Stage of Development, 2014 9 Indian Immunologicals Limited - Monotherapy Products in Pipeline, 2014 10 Indian Immunologicals Limited - Phase I, 2014 11 Indian Immunologicals Limited - Preclinical, 2014 12 Indian Immunologicals Limited - Unknown, 2014 13 Indian Immunologicals Limited - Pipeline by Route of Administration, 2014 24 Indian Immunologicals Limited - Pipeline by Molecule Type, 2014 25 Indian Immunologicals Limited - Dormant Developmental Projects,2014 26 Indian Immunologicals Limited, Other Locations 27
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.